These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 19147322)
1. Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication". Bhasin N; Parry DJ; Scott DJ; Ariëns RA; Grant PJ; West RM J Vasc Surg; 2009 Apr; 49(4):1088-9. PubMed ID: 19147322 [No Abstract] [Full Text] [Related]
2. Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication. Bhasin N; Ariëns RA; West RM; Parry DJ; Grant PJ; Scott DJ J Vasc Surg; 2008 Dec; 48(6):1497-503, 1503.e1. PubMed ID: 18829228 [TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication. Parry DJ; Grant PJ; Scott DJ Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597 [TBL] [Abstract][Full Text] [Related]
4. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Carter AM; Cymbalista CM; Spector TD; Grant PJ; Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2783-9. PubMed ID: 17932316 [TBL] [Abstract][Full Text] [Related]
5. Endogenous heparin activity is decreased in peripheral arterial occlusive disease. Shankar VK; Handa A; Hands L J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667 [TBL] [Abstract][Full Text] [Related]
6. How many claudicants should be prescribed statins? Harrison EM; Holdsworth RJ Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177 [No Abstract] [Full Text] [Related]
7. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease. Smith FB; Connor JM; Lee AJ; Cooke A; Lowe GD; Rumley A; Fowkes FG Thromb Res; 2003; 112(4):209-16. PubMed ID: 14987913 [TBL] [Abstract][Full Text] [Related]
8. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity. Tayebjee MH; Tan KT; MacFadyen RJ; Lip GY J Intern Med; 2005 Jan; 257(1):110-6. PubMed ID: 15606382 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of beta(2)-microglobulin, a biomarker of peripheral arterial disease, are not affected by maximal leg exercise in patients with intermittent claudication. Busti C; Migliacci R; Falcinelli E; Gresele P Atherosclerosis; 2009 Mar; 203(1):38-40. PubMed ID: 18674763 [No Abstract] [Full Text] [Related]
15. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1). Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383 [TBL] [Abstract][Full Text] [Related]
16. Anti-platelet therapy: is it all over in peripheral artery disease? Jaipersad AS; Silverman SH; Lip GY Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749 [No Abstract] [Full Text] [Related]